Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Commentary on clinical use of finerenone, a novel nonsteroidal MR antagonist for CKD in T2D, from Clinical Care Options (CCO)
Concise microlearning module featuring expert insight on the cardiorenal benefits of finerenone in T2D and CKD from Clinical Care Options (CCO)
Commentary on clinical use of SGLT2 inhibitors in diabetic kidney disease, from Clinical Care Options (CCO)
Concise microlearning module featuring expert insight on the cardiorenal benefits of SGLT2 inhibitors in T2D from Clinical Care Options (CCO)
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.